Brief: Tianda Pharmaceuticals Sees FY Loss Attributable Of Hk$27 Million
18/06/2021 15:56
Tianda Pharmaceuticals Ltd 0455.HK :
* TIANDA PHARMACEUTICALS SEES FY LOSS ATTRIBUTABLE OF HK$27
MILLION
* TIANDA PHARMACEUTICALS - EXPECTED RESULT AS REVENUE AND
GROSS
PROFIT OF DRUGS & MEDICAL TECHNOLOGIES BUSINESS DECLINED
Source text for Eikon: ID:
Further company coverage: 0455.HK
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA